Laird Norton Wetherby Wealth Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laird Norton Wetherby Wealth Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,562,749
-7.2%
101,018
-5.8%
0.09%
-2.2%
Q2 2023$1,684,411
-9.1%
107,219
-4.6%
0.09%
-15.7%
Q1 2023$1,853,061
+16.4%
112,443
+10.1%
0.11%
+5.9%
Q4 2022$1,592,479
+18.8%
102,082
-1.3%
0.10%
+7.4%
Q3 2022$1,341,000
+6.3%
103,427
+15.0%
0.10%
+10.5%
Q2 2022$1,262,000
-38.9%
89,915
-37.6%
0.09%
-27.1%
Q1 2022$2,065,000
+110.7%
144,207
+100.5%
0.12%
+114.5%
Q4 2021$980,000
-11.0%
71,925
+7.0%
0.06%
-19.1%
Q3 2021$1,101,000
+12.6%
67,189
+15.7%
0.07%
+13.3%
Q2 2021$978,000
+29.5%
58,090
+40.4%
0.06%
+3.4%
Q1 2021$755,000
-0.3%
41,376
-0.6%
0.06%
+13.7%
Q4 2020$757,000
-23.9%
41,620
-25.4%
0.05%
-42.7%
Q3 2020$995,000
+12.3%
55,757
+12.8%
0.09%
+6.0%
Q2 2020$886,000
+117.7%
49,431
+84.5%
0.08%
+82.6%
Q1 2020$407,000
-52.4%
26,799
-38.2%
0.05%
-45.2%
Q4 2019$855,000
+43.7%
43,359
+25.3%
0.08%
+35.5%
Q3 2019$595,000
+51.8%
34,613
+56.3%
0.06%
+44.2%
Q2 2019$392,000
-44.7%
22,145
-36.4%
0.04%
-51.1%
Q1 2019$709,00034,8050.09%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders